glp 1 receptor agonist moa A Closer Look at the Dermatological Profile of GLP-1 Agonists Weight Loss and Maintenance Related
Description
This review evaluates the current available evidence for GLP-1 receptor agonists, dual GLP-1/GIP receptor co-agonists with a focus on GLP-1/GIP/glucagon receptor triagonists and discusses the potential future benefits and research directions
Insurance may cover drug costs for diabetes treatment, but weight loss patients face approval challenges
Indications Both Trulicity and Ozempic are indicated for use in adults with type 2 diabetes to improve glycemic control
doi: 10.1007/s00125-014-3171-6
Additionally, if the FDA approves more uses for these medicines, insurance companies will be less likely to object to prescribing GLP-1s for uses beyond diabetes and weight loss
Finan B, Ma T, Ottaway N, et al
